263 related articles for article (PubMed ID: 27377307)
1. Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells.
Ying TH; Lee CH; Chiou HL; Yang SF; Lin CL; Hung CH; Tsai JP; Hsieh YH
Sci Rep; 2016 Jul; 6():29385. PubMed ID: 27377307
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo.
Tung JN; Ko CP; Yang SF; Cheng CW; Chen PN; Chang CY; Lin CL; Yang TF; Hsieh YH; Chen KC
J Neurooncol; 2016 Sep; 129(2):201-9. PubMed ID: 27278519
[TBL] [Abstract][Full Text] [Related]
3. Oleate-induced PTX3 promotes head and neck squamous cell carcinoma metastasis through the up-regulation of vimentin.
Chan SH; Tsai JP; Shen CJ; Liao YH; Chen BK
Oncotarget; 2017 Jun; 8(25):41364-41378. PubMed ID: 28489600
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-224 inhibition prevents progression of cervical carcinoma by targeting PTX3.
Yu LM; Wang WW; Qi R; Leng TG; Zhang XL
J Cell Biochem; 2018 Dec; 119(12):10278-10290. PubMed ID: 30129088
[TBL] [Abstract][Full Text] [Related]
5. Pentraxin 3 acts as a functional effector of Akt/NF-κB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer.
Li Y; Song X; Niu J; Ren M; Tang G; Sun Z; Kong F
Arch Biochem Biophys; 2021 Apr; 701():108818. PubMed ID: 33617838
[TBL] [Abstract][Full Text] [Related]
6. PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.
Chang WC; Wu SL; Huang WC; Hsu JY; Chan SH; Wang JM; Tsai JP; Chen BK
Oncotarget; 2015 Apr; 6(10):7741-57. PubMed ID: 25797258
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of the inflammatory factor pentraxin-3 suppresses growth and invasion of lung adenocarcinoma through the AKT and NF-kappa B pathways.
Hu FQ; Qiao T; Xie X; Hu R; Xiao HB
J Biol Regul Homeost Agents; 2014; 28(4):649-57. PubMed ID: 25620175
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.
Margheri F; Serratì S; Lapucci A; Chillà A; Bazzichi L; Bombardieri S; Kahaleh B; Calorini L; Bianchini F; Fibbi G; Del Rosso M
Arthritis Rheum; 2010 Aug; 62(8):2488-98. PubMed ID: 20506099
[TBL] [Abstract][Full Text] [Related]
9. Tumor endothelial cells express high pentraxin 3 levels.
Hida K; Maishi N; Kawamoto T; Akiyama K; Ohga N; Hida Y; Yamada K; Hojo T; Kikuchi H; Sato M; Torii C; Shinohara N; Shindoh M
Pathol Int; 2016 Dec; 66(12):687-694. PubMed ID: 27862647
[TBL] [Abstract][Full Text] [Related]
10. Pentraxin 3 Modulates the Inflammatory Response in Human Dental Pulp Cells.
Kim Y; Park JS; Park HJ; Kim MK; Kim YI; Bae SK; Kim HJ; Jeong CH; Bae MK
J Endod; 2018 Dec; 44(12):1826-1831. PubMed ID: 30477668
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory Role of Pentraxin-3 in Esophageal Squamous Cell Carcinoma.
Ma D; Zong Y; Zhu ST; Wang YJ; Li P; Zhang ST
Chin Med J (Engl); 2016 Sep; 129(18):2233-40. PubMed ID: 27625097
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin-3 Modulates Osteogenic/Odontogenic Differentiation and Migration of Human Dental Pulp Stem Cells.
Kim Y; Park JY; Park HJ; Kim MK; Kim YI; Kim HJ; Bae SK; Bae MK
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744201
[TBL] [Abstract][Full Text] [Related]
13. Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.
Choi B; Lee EJ; Song DH; Yoon SC; Chung YH; Jang Y; Kim SM; Song Y; Kang SW; Yoon SY; Chang EJ
Oncotarget; 2014 Jan; 5(2):481-92. PubMed ID: 24457902
[TBL] [Abstract][Full Text] [Related]
14. IL‑1β‑induced pentraxin 3 inhibits the proliferation, invasion and cell cycle of trophoblasts in preeclampsia and is suppressed by IL‑1β antagonists.
Wang X; Zhang J; Ji J
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35137920
[TBL] [Abstract][Full Text] [Related]
15. Tunicamycin enhances the suppressive effects of cisplatin on lung cancer growth through PTX3 glycosylation via AKT/NF-κB signaling pathway.
Ahmmed B; Khan MN; Nisar MA; Kampo S; Zheng Q; Li Y; Yan Q
Int J Oncol; 2019 Feb; 54(2):431-442. PubMed ID: 30483742
[TBL] [Abstract][Full Text] [Related]
16. Pentraxin-3 Silencing Suppresses Gastric Cancer-related Inflammation by Inhibiting Chemotactic Migration of Macrophages.
Choi B; Lee EJ; Park YS; Kim SM; Kim EY; Song Y; Kang SW; Rhu MH; Chang EJ
Anticancer Res; 2015 May; 35(5):2663-8. PubMed ID: 25964543
[TBL] [Abstract][Full Text] [Related]
17. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
[TBL] [Abstract][Full Text] [Related]
18. Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.
Chi JY; Hsiao YW; Li CF; Lo YC; Lin ZY; Hong JY; Liu YM; Han X; Wang SM; Chen BK; Tsai KK; Wang JM
Oncotarget; 2015 Sep; 6(27):23987-4001. PubMed ID: 26124179
[TBL] [Abstract][Full Text] [Related]
19. Effects of DCK knockdown on proliferation, apoptosis and tumorigenicity in vivo of cervical cancer HeLa cells.
Shang QY; Wu CS; Gao HR
Cancer Gene Ther; 2017 Sep; 24(9):367-372. PubMed ID: 28820179
[TBL] [Abstract][Full Text] [Related]
20. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
